vs
Side-by-side financial comparison of indie Semiconductor, Inc. (INDI) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $58.0M, roughly 1.3× indie Semiconductor, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -0.0%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-16.1M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 5.3%).
indie Semiconductor is a fabless semiconductor manufacturer focused on designing high-performance mixed-signal and embedded system-on-chip solutions for the automotive industry. Its products support advanced driver assistance systems, in-vehicle infotainment, connected car, and electric vehicle applications, serving global auto OEMs and tier 1 suppliers across major global markets.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
INDI vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.0M | $75.5M |
| Net Profit | $-31.2M | — |
| Gross Margin | 37.3% | 69.3% |
| Operating Margin | -58.5% | 22.7% |
| Net Margin | -53.8% | — |
| Revenue YoY | -0.0% | 27.7% |
| Net Profit YoY | 9.1% | — |
| EPS (diluted) | $-0.16 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.0M | $75.5M | ||
| Q3 25 | $53.7M | $54.5M | ||
| Q2 25 | $51.6M | $52.4M | ||
| Q1 25 | $54.1M | $46.0M | ||
| Q4 24 | $58.0M | $59.1M | ||
| Q3 24 | $54.0M | $80.5M | ||
| Q2 24 | $52.4M | $47.1M | ||
| Q1 24 | $52.4M | $43.8M |
| Q4 25 | $-31.2M | — | ||
| Q3 25 | $-38.3M | $8.8M | ||
| Q2 25 | $-39.0M | $5.9M | ||
| Q1 25 | $-34.5M | $3.0M | ||
| Q4 24 | $-34.4M | — | ||
| Q3 24 | $-49.7M | $20.3M | ||
| Q2 24 | $-19.2M | $-4.5M | ||
| Q1 24 | $-31.2M | $-4.8M |
| Q4 25 | 37.3% | 69.3% | ||
| Q3 25 | 40.1% | 77.7% | ||
| Q2 25 | 40.6% | 76.5% | ||
| Q1 25 | 41.7% | 77.1% | ||
| Q4 24 | 42.6% | 76.4% | ||
| Q3 24 | 39.3% | 63.9% | ||
| Q2 24 | 42.2% | 77.4% | ||
| Q1 24 | 42.5% | 75.5% |
| Q4 25 | -58.5% | 22.7% | ||
| Q3 25 | -71.4% | 17.6% | ||
| Q2 25 | -83.3% | 12.7% | ||
| Q1 25 | -72.0% | 8.7% | ||
| Q4 24 | -58.4% | 22.6% | ||
| Q3 24 | -92.5% | 27.4% | ||
| Q2 24 | -70.0% | -4.6% | ||
| Q1 24 | -94.8% | -5.3% |
| Q4 25 | -53.8% | — | ||
| Q3 25 | -71.3% | 16.2% | ||
| Q2 25 | -75.6% | 11.2% | ||
| Q1 25 | -63.9% | 6.5% | ||
| Q4 24 | -59.2% | — | ||
| Q3 24 | -92.1% | 25.2% | ||
| Q2 24 | -36.6% | -9.6% | ||
| Q1 24 | -59.6% | -11.0% |
| Q4 25 | $-0.16 | $0.26 | ||
| Q3 25 | $-0.19 | $0.17 | ||
| Q2 25 | $-0.20 | $0.12 | ||
| Q1 25 | $-0.18 | $0.06 | ||
| Q4 24 | $-0.18 | $0.40 | ||
| Q3 24 | $-0.28 | $0.41 | ||
| Q2 24 | $-0.11 | $-0.09 | ||
| Q1 24 | $-0.19 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $145.5M | $97.5M |
| Total DebtLower is stronger | $353.4M | $22.7M |
| Stockholders' EquityBook value | $358.0M | $130.3M |
| Total Assets | $840.8M | $216.3M |
| Debt / EquityLower = less leverage | 0.99× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $145.5M | $97.5M | ||
| Q3 25 | $160.9M | $94.4M | ||
| Q2 25 | $192.6M | $96.0M | ||
| Q1 25 | $236.6M | $93.2M | ||
| Q4 24 | $274.2M | $101.0M | ||
| Q3 24 | $96.9M | $96.7M | ||
| Q2 24 | $112.3M | $96.8M | ||
| Q1 24 | $138.2M | $107.2M |
| Q4 25 | $353.4M | $22.7M | ||
| Q3 25 | $353.5M | $34.0M | ||
| Q2 25 | $352.5M | $45.3M | ||
| Q1 25 | $379.0M | $56.7M | ||
| Q4 24 | $381.3M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $358.0M | $130.3M | ||
| Q3 25 | $369.2M | $115.3M | ||
| Q2 25 | $390.4M | $104.7M | ||
| Q1 25 | $405.6M | $97.1M | ||
| Q4 24 | $417.9M | $92.1M | ||
| Q3 24 | $458.6M | $71.1M | ||
| Q2 24 | $470.7M | $48.5M | ||
| Q1 24 | $432.9M | $51.0M |
| Q4 25 | $840.8M | $216.3M | ||
| Q3 25 | $855.1M | $202.9M | ||
| Q2 25 | $867.6M | $194.9M | ||
| Q1 25 | $909.0M | $196.2M | ||
| Q4 24 | $941.4M | $213.3M | ||
| Q3 24 | $797.5M | $220.7M | ||
| Q2 24 | $797.3M | $205.0M | ||
| Q1 24 | $803.6M | $214.1M |
| Q4 25 | 0.99× | 0.17× | ||
| Q3 25 | 0.96× | 0.30× | ||
| Q2 25 | 0.90× | 0.43× | ||
| Q1 25 | 0.93× | 0.58× | ||
| Q4 24 | 0.91× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.4M | $14.4M |
| Free Cash FlowOCF − Capex | $-16.1M | $14.4M |
| FCF MarginFCF / Revenue | -27.8% | 19.1% |
| Capex IntensityCapex / Revenue | 3.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-71.4M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-14.4M | $14.4M | ||
| Q3 25 | $-6.2M | $9.7M | ||
| Q2 25 | $-7.6M | $14.1M | ||
| Q1 25 | $-29.0M | $3.6M | ||
| Q4 24 | $-6.7M | $15.6M | ||
| Q3 24 | $-22.8M | $11.0M | ||
| Q2 24 | $-19.7M | $1.0M | ||
| Q1 24 | $-9.3M | $11.2M |
| Q4 25 | $-16.1M | $14.4M | ||
| Q3 25 | $-10.3M | $9.7M | ||
| Q2 25 | $-13.6M | $14.1M | ||
| Q1 25 | $-31.4M | $3.6M | ||
| Q4 24 | $-8.6M | $15.6M | ||
| Q3 24 | $-29.3M | $11.0M | ||
| Q2 24 | $-23.4M | $1.0M | ||
| Q1 24 | $-11.7M | — |
| Q4 25 | -27.8% | 19.1% | ||
| Q3 25 | -19.2% | 17.7% | ||
| Q2 25 | -26.4% | 26.8% | ||
| Q1 25 | -58.0% | 7.7% | ||
| Q4 24 | -14.8% | 26.4% | ||
| Q3 24 | -54.3% | 13.7% | ||
| Q2 24 | -44.7% | 2.1% | ||
| Q1 24 | -22.3% | — |
| Q4 25 | 3.0% | 0.0% | ||
| Q3 25 | 7.8% | 0.0% | ||
| Q2 25 | 11.6% | 0.0% | ||
| Q1 25 | 4.4% | 0.1% | ||
| Q4 24 | 3.2% | 0.0% | ||
| Q3 24 | 12.1% | 0.0% | ||
| Q2 24 | 7.0% | 0.0% | ||
| Q1 24 | 4.4% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INDI
| Products | $55.7M | 96% |
| Services | $2.3M | 4% |
PBYI
Segment breakdown not available.
